The prostate cancer antigen 3 (PCA3) is a long non-coding RNA (lncRNA) with high level of
specificity for prostate cancer. This lncRNA has fundamental effects in the prostate …

From a single restriction fragment length polymorphism analysis to next generation
sequencing analysis that screens the entire human genome, testing for genomic variations …

Background: Choriocarcinoma is the most aggressive gestational trophoblastic disease, with
massive local trophoblast invasion and vascular percolation, resulting in multiple organ …

Background: Forkhead box F2, a member of the Forkhead box transcription factor
superfamily, plays an important role in several types of cancer. However, the mechanisms of …

Materials and Methods: The buffy coat was collected from peripheral blood of thirty untreated
CML patients (BCR-ABL positive) and twenty normal volunteers. RNA was extracted from …

Abstract Background Prostate cancer (PCa) diagnosis requires improvement with the aid of
more accurate biomarkers. Postejaculate urethral washings (PEUW) could be a …

Background Atorvastatin and metformin are known energy restricting mimetic agents that act
synergistically to produce molecular and metabolic changes in advanced prostate cancer …

Abstract Objectives Long noncoding RNAs (lncRNAs) plays important role in disease spread
and its invasion. Overexpression of prostate cancer antigen 3 gene (PCA3gene) is reported …

Background Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in
prostate cancer (PCa). We recently identified a short ncRNA expressed from intron 1 of …

Prostate cancer (PCa) is the most common cancer in men. It is a heterogeneous disease
and currently there are no reliable biomarkers available to stratify men for prostate biopsy …